Kanuu

Kanuu helps MedTech and HealthTech companies de-risk innovation early. We specialize in early Health Technology Assessment (eHTA), giving innovation teams structured, evidence-based answers on market viability before costly development commitments.

Our approach combines the RWW (Real, Win, Worth it) framework with AI-driven synthetic personas that simulate stakeholder perspectives across hospital types, regions, and roles. This means faster, cheaper validation cycles without waiting months for traditional market research.

Together with Radboud UMC and Fraunhofer IESE, we're building Kaleidoscope, a platform that makes this methodology scalable for MedTech teams across Europe. From quick scans to full innovation assessments, we act as a force multiplier for teams that need sharper upstream decisions.